CAR T-cell therapy is a type of cancer therapy that uses a patient’s own
modified white blood cells to kill cancer cells. T cells are changed in the
laboratory. The gene for
a special receptor called a chimeric antigen receptor (CAR) will insert into
the T cells. Then millions of the CAR T
cells are grown in the laboratory and then given to the patient by infusion.
The CAR T cells are able to bind to an antigen on the cancer cells and kill
them.
About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud